Kindstar Globalgene Technology, Inc.

HKEX:9960.HK

1.19 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 236.668236.668237.25237.25246.38246.38363.555363.555329.741329.741246.237246.237219.1219.1230.939230.939214.757214.757
Cost of Revenue 123.773123.773133.105133.105124.42124.42209.241209.241180.413180.413119.152119.152102.224102.224107.994107.994108.089108.089
Gross Profit 112.895112.895104.145104.145121.96121.96154.314154.314149.328149.328127.085127.085116.877116.877122.945122.945106.668106.668
Gross Profit Ratio 0.4770.4770.4390.4390.4950.4950.4240.4240.4530.4530.5160.5160.5330.5330.5320.5320.4970.497
Reseach & Development Expenses 24.20124.20126.27726.27726.39226.39228.23328.23322.3822.3823.98323.98321.1821.1821.75421.75415.88715.887
General & Administrative Expenses 23.38423.38428.18828.18824.62524.62520.78920.78919.41519.41520.32820.32814.42914.42914.79214.79211.36811.368
Selling & Marketing Expenses 73.96273.96274.09774.09779.79479.79497.53897.53882.74382.74373.34273.34267.77967.77968.45268.45255.80955.809
SG&A 97.34597.345102.285102.285104.419104.419118.327118.327102.158102.15893.66993.66982.20882.20883.24483.24467.17767.177
Other Expenses 000000000000000000
Operating Expenses 121.546121.546128.561125.66116.184116.184161.815161.815124.563124.563108.713108.713867.591867.591562.416562.416148.951148.951
Operating Income -8.651-8.651-24.416-26.379-15.615-15.6151.6911.69111.90711.9076.1496.1497.9157.91517.70617.70617.64417.644
Operating Income Ratio -0.037-0.037-0.103-0.111-0.063-0.0630.0050.0050.0360.0360.0250.0250.0360.0360.0770.0770.0820.082
Total Other Income Expenses Net 16.18516.18522.72722.72732.20132.201-2.462-2.46211.57511.57512.94612.946-762.863-762.863-456.437-456.437-60.09-60.09
Income Before Tax 7.5357.535-1.689-1.68923.3523.355.2935.29336.36636.36622.3822.38-749.374-749.374-438.731-438.731-42.446-42.446
Income Before Tax Ratio 0.0320.032-0.007-0.0070.0950.0950.0150.0150.110.110.0910.091-3.42-3.42-1.9-1.9-0.198-0.198
Income Tax Expense 2.2712.2711.8321.8321.6061.6061.8351.8354.7514.7510.1820.1820.3050.3050.9130.9132.9712.971
Net Income 5.9485.948-1.348-1.34821.99121.9916.4616.46131.26831.26823.63623.636-750.851-750.851-440.907-440.907-46.104-46.104
Net Income Ratio 0.0250.025-0.006-0.0060.0890.0890.0180.0180.0950.0950.0960.096-3.427-3.427-1.909-1.909-0.215-0.215
EPS 0.0060.006-0.004-0.0040.0230.0230.010.010.030.030.0280.028-5.17-5.17-3.76-3.76-0.43-0.43
EPS Diluted 0.0060.006-0.001-0.0010.0230.0230.010.010.0310.0310.0280.028-5.17-5.17-3.76-3.76-0.43-0.43
EBITDA -5.557-5.557-15.031-15.031-1.799-1.79913.35813.35824.38924.38914.3514.3517.57517.57524.97124.97127.61527.615
EBITDA Ratio -0.023-0.023-0.063-0.063-0.007-0.0070.0370.0370.0740.0740.0580.0580.080.080.1080.1080.1290.129